Pfizer's Xeljanz gets FDA nod as joint disease treatment

(Reuters) - U.S. drugmaker Pfizer Inc said on Thursday the U.S. Food and Drug Administration (FDA) approved two doses of its drug Xeljanz for treatment of a joint disease.

from Reuters: Health News http://reut.rs/2o4lOzM